Chris Abbosh

Oncology R&D Strategy
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of Treatment.

Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of Treatment.

Journal: JCO precision oncology
Published: October 30, 2025

Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non-Small Cell Lung Cancers.

Clinicopathological Predictors of the Presence of Blood Circulating Tumor DNA in Early-Stage Non-Small Cell Lung Cancers.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 25, 2024

Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer.

Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 19, 2024

Reply to S. Sorscher.

Reply to S. Sorscher.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2024

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2024

Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC.

Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 02, 2024

Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancer.

Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancer.

Journal: Cancer letters
Published: March 19, 2024

Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer.

Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer.

Journal: Trends in cancer
Published: February 28, 2024

Embracing cancer complexity: Hallmarks of systemic disease.

Embracing cancer complexity: Hallmarks of systemic disease.

Journal: Cell
Published: September 25, 2023

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Journal: Nature
Published: December 16, 2022

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 28, 2021

Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.

Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.

Journal: Nature medicine
Published: June 05, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026